NURECANSENureca Limited· Healthcare Equipment & SuppliesHighNegative
Announced Wed, 7 Jan, 2026 · 17:44 IST

Nureca Limited has informed the Exchange about General Updates

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.1%Reaction day
₹295.20
prior close
₹295.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.9%+0.8% vs market
Medical Equipment & Supplies peers, median of 13sector-2.1%+1.0% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.0 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
+0.5
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.1-1.9+0.8-2.1+1.0
Next day
-4.2-3.6-0.6-2.8-1.4
2d
-5.5-4.4-1.1-4.4-1.1
3d
-0.8-4.1+3.3-3.5+2.7
4d
+1.0-4.1+5.2-6.8+7.8
5d
+5.6-4.5+10.2-6.8+12.4
1w
+5.2-8.3+13.5-10.4+15.6
15d
-7.8-7.5-0.3-11.9+4.1
1m
-2.8-2.1-0.7-9.7+7.0
2m
-11.6-12.3+0.7-17.4+5.8
3m
-13.4-7.4-6.0-14.3+0.9
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nureca Limited has received warning letters from BSE on January 6, 2026 and from NSE on January 7, 2026. The reason is a compliance lapse — the company did not hold any meeting of the Stakeholders Relationship Committee during the financial year ended March 2025, which is required under Regulation 20(3A) of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. Both exchanges have asked the company to exercise greater diligence, take corrective steps, and warned that any future non-compliance could attract stricter action. The company has disclosed that this lapse has no financial or operational impact. The company is required to share the warning letters with the stock exchanges and place them before its Board of Directors.

Likely market impact

This is a minor procedural compliance issue, not a financial or legal one. There is no direct impact on earnings or operations, but repeated lapses could lead to stricter regulatory action or damage investor confidence in the company's governance standards.